Literature DB >> 20926794

Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.

Philippe Saikali1, Jack P Antel, Camille L Pittet, Jia Newcombe, Nathalie Arbour.   

Abstract

The contribution of local factors to the activation of immune cells infiltrating the CNS of patients with multiple sclerosis (MS) remains to be defined. The cytokine IL-15 is pivotal in the maintenance and activation of CD8 T lymphocytes, a prominent lymphocyte population found in MS lesions. We investigated whether astrocytes are a functional source of IL-15 sufficient to enhance CD8 T lymphocyte responses and whether they provide IL-15 in the inflamed CNS of patients with MS. We observed that human astrocytes in primary cultures increased surface IL-15 levels upon activation with combinations of proinflammatory cytokines. Expanded human myelin autoreactive CD8 T lymphocytes cultured with such activated astrocytes displayed elevated lytic enzyme content, NKG2D expression, and Ag-specific cytotoxicity. These functional enhancements were abrogated by anti-IL-15-blocking Abs. Immunohistochemical analysis of brain tissue sections obtained from patients with MS demonstrated colocalization for IL-15 and the astrocyte marker glial fibrillary acidic protein within white matter lesions. The majority of astrocytes (80-90%) present in demyelinating MS lesions expressed IL-15, whereas few astrocytes in normal control brain sections had detectable IL-15. IL-15 could be detected in the majority of Iba-1-expressing microglia in the control sections, albeit in lower numbers when compared with microglia/macrophages in MS lesions. Furthermore, infiltrating CD8 T lymphocytes in MS lesions were in close proximity to IL-15-expressing cells. Astrocyte production of IL-15 resulting in the activation of CD8 T lymphocytes ascribes a role for these cells as contributors to the exacerbation of tissue damage during MS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926794     DOI: 10.4049/jimmunol.1002188

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

Review 1.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Immune players in the CNS: the astrocyte.

Authors:  Cathy J Jensen; Ann Massie; Jacques De Keyser
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-04       Impact factor: 4.147

Review 3.  Biomarker studies in multiple sclerosis: from proteins to noncoding RNAs.

Authors:  Xiao-Fang Liu; Yue-Bei Luo; Zhao-Hui Luo; Huan Yang
Journal:  Neurochem Res       Date:  2014-07-29       Impact factor: 3.996

4.  The role of IL-15 in activating STAT5 and fine-tuning IL-17A production in CD4 T lymphocytes.

Authors:  Pushpa Pandiyan; Xiang-Ping Yang; Senthil S Saravanamuthu; Lixin Zheng; Satoru Ishihara; John J O'Shea; Michael J Lenardo
Journal:  J Immunol       Date:  2012-09-19       Impact factor: 5.422

5.  Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.

Authors:  Luzhou Xing; Zhenpeng Dai; Ali Jabbari; Jane E Cerise; Claire A Higgins; Weijuan Gong; Annemieke de Jong; Sivan Harel; Gina M DeStefano; Lisa Rothman; Pallavi Singh; Lynn Petukhova; Julian Mackay-Wiggan; Angela M Christiano; Raphael Clynes
Journal:  Nat Med       Date:  2014-08-17       Impact factor: 53.440

6.  Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update.

Authors:  Honglei Ren; Ranran Han; Xuemei Chen; Xi Liu; Jieru Wan; Limin Wang; Xiuli Yang; Jian Wang
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-19       Impact factor: 6.200

Review 7.  Interaction of astrocytes and T cells in physiological and pathological conditions.

Authors:  Luokun Xie; Shao-Hua Yang
Journal:  Brain Res       Date:  2015-03-23       Impact factor: 3.252

8.  B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients.

Authors:  Raphael Schneider; Alma Nazlie Mohebiany; Igal Ifergan; Diane Beauseigle; Pierre Duquette; Alexandre Prat; Nathalie Arbour
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

9.  Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.

Authors:  Lisi Flores-Aguilar; M Florencia Iulita; Olivia Kovecses; Maria D Torres; Sarah M Levi; Yian Zhang; Manor Askenazi; Thomas Wisniewski; Jorge Busciglio; A Claudio Cuello
Journal:  Brain       Date:  2020-12-01       Impact factor: 13.501

Review 10.  Brain interleukin-15 in neuroinflammation and behavior.

Authors:  Weihong Pan; Xiaojun Wu; Yi He; Hung Hsuchou; Eagle Yi-Kung Huang; Pramod K Mishra; Abba J Kastin
Journal:  Neurosci Biobehav Rev       Date:  2012-11-29       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.